138 related articles for article (PubMed ID: 11587054)
1. Vascular disease in younger-onset diabetes: comparison of European, Asian and American Indian cohorts of the WHO Multinational Study of Vascular Disease in Diabetes.
Lee ET; Lu M; Bennett PH; Keen H
Diabetologia; 2001 Sep; 44 Suppl 2():S78-81. PubMed ID: 11587054
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes.
Chaturvedi N; Stevens LK; Fuller JH; Lee ET; Lu M
Diabetologia; 2001 Sep; 44 Suppl 2():S65-71. PubMed ID: 11587052
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity.
Lee ET; Keen H; Bennett PH; Fuller JH; Lu M
Diabetologia; 2001 Sep; 44 Suppl 2():S3-13. PubMed ID: 11587047
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in Diabetes.
Colhoun HM; Lee ET; Bennett PH; Lu M; Keen H; Wang SL; Stevens LK; Fuller JH
Diabetologia; 2001 Sep; 44 Suppl 2():S46-53. PubMed ID: 11587050
[TBL] [Abstract][Full Text] [Related]
5. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes.
Chi ZS; Lee ET; Lu M; Keen H; Bennett PH
Diabetologia; 2001 Sep; 44 Suppl 2():S82-6. PubMed ID: 11587055
[TBL] [Abstract][Full Text] [Related]
6. The incidence of visual impairment and its determinants in the WHO Multinational Study of Vascular Disease in Diabetes.
Miki E; Lu M; Lee ET; Keen H; Bennett PH; Russell D
Diabetologia; 2001 Sep; 44 Suppl 2():S31-6. PubMed ID: 11587048
[TBL] [Abstract][Full Text] [Related]
7. The appearance of retinopathy and progression to proliferative retinopathy: the WHO Multinational Study of Vascular Disease in Diabetes.
Keen H; Lee ET; Russell D; Miki E; Bennett PH; Lu M
Diabetologia; 2001 Sep; 44 Suppl 2():S22-30. PubMed ID: 11587046
[TBL] [Abstract][Full Text] [Related]
8. Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes.
Bennett PH; Lee ET; Lu M; Keen H; Fuller JH
Diabetologia; 2001 Sep; 44 Suppl 2():S37-45. PubMed ID: 11587049
[TBL] [Abstract][Full Text] [Related]
9. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.
Morrish NJ; Wang SL; Stevens LK; Fuller JH; Keen H
Diabetologia; 2001 Sep; 44 Suppl 2():S14-21. PubMed ID: 11587045
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of chronic complications in Japanese diabetic patients.
Kuzuya T; Akanuma Y; Akazawa Y; Uehata T
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S159-64. PubMed ID: 7859600
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes.
Fuller JH; Stevens LK; Wang SL
Diabetologia; 2001 Sep; 44 Suppl 2():S54-64. PubMed ID: 11587051
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. CODIAB-INSERM-ZENECA Pharma Study Group.
Delcourt C; Vauzelle-Kervroedan F; Cathelineau G; Papoz L
J Diabetes Complications; 1998; 12(2):88-95. PubMed ID: 9559486
[TBL] [Abstract][Full Text] [Related]
13. Incidence of macrovascular disease in diabetes mellitus: the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics.
Morrish NJ; Stevens LK; Fuller JH; Keen H; Jarrett RJ
Diabetologia; 1991 Aug; 34(8):584-9. PubMed ID: 1936662
[TBL] [Abstract][Full Text] [Related]
14. Model of complications of NIDDM. I. Model construction and assumptions.
Eastman RC; Javitt JC; Herman WH; Dasbach EJ; Zbrozek AS; Dong F; Manninen D; Garfield SA; Copley-Merriman C; Maier W; Eastman JF; Kotsanos J; Cowie CC; Harris M
Diabetes Care; 1997 May; 20(5):725-34. PubMed ID: 9135934
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus in Hopi and Navajo indians. Prevalence of microvascular complications.
Rate RG; Knowler WC; Morse HG; Bonnell MD; McVey J; Chervenak CL; Smith MG; Pavanich G
Diabetes; 1983 Oct; 32(10):894-9. PubMed ID: 6618018
[TBL] [Abstract][Full Text] [Related]
16. Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study.
Lee ET; Lee VS; Lu M; Lee JS; Russell D; Yeh J
Diabetes; 1994 Apr; 43(4):572-9. PubMed ID: 8138063
[TBL] [Abstract][Full Text] [Related]
17. Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors.
Lee ET; Lee VS; Kingsley RM; Lu M; Russell D; Asal NR; Wilkinson CP; Bradford RH
Diabetes Care; 1992 Nov; 15(11):1620-7. PubMed ID: 1468294
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of diabetes and factors associated with diabetic complications in Oneida Indians.
Schulz LO; Lalicata M; Carnes D; Rith-Najarian SJ
Life Sci; 1997; 60(4-5):299-306. PubMed ID: 9010485
[TBL] [Abstract][Full Text] [Related]
19. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria.
Nelson RG; Knowler WC; McCance DR; Sievers ML; Pettitt DJ; Charles MA; Hanson RL; Liu QZ; Bennett PH
Diabetologia; 1993 Oct; 36(10):1087-93. PubMed ID: 8243859
[TBL] [Abstract][Full Text] [Related]
20. Young-onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications.
Middleton TL; Constantino MI; Molyneaux L; D'Souza M; Twigg SM; Wu T; Yue DK; Zoungas S; Wong J
Diabet Med; 2020 Jun; 37(6):991-999. PubMed ID: 31968129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
